Article

How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to Know

2025-12-03

Abstract excerpt

Acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDS) are clonal hematopoietic malignancies in which next-generation sequencing (NGS) has become integral for diagnosis, classification, risk stratification, and measurable residual disease (MRD) monitoring. Traditional cytogenetic and PCR-based assays remain useful, but targeted NGS panels now represent the standard of care, providing rapid and sensitive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3e2970c-8b3c-505c-9240-37708e0b2e2f
DOI: 10.20944/preprints202511.0013.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to KnowDOI 10.20944/preprints202511.0013.v2Read

How to Read a Next-Generation Sequencing Report for AML and MDS—What Hematologists Need to KnowSemantic proximity Read

Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.Semantic proximity Read

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.Semantic proximity Read

Next Generation Sequencing of Acute Myeloid Leukemia: Influencing PrognosisSemantic proximity Read

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read

The role of next-generation sequencing in acute myeloid leukemia.Semantic proximity Read

The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.Semantic proximity Read

[Chinese expert consensus on the clinical application of next-generation sequencing technology in myelodysplastic neoplasms (2026)].Semantic proximity Read

Advances in DNA/RNA Sequencing and Their Applications in Acute Myeloid Leukemia (AML)Semantic proximity Read

Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.Semantic proximity Read

Biomarkers and advances in AML-MRC: from bench to bedside.Semantic proximity Read

Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemiaSemantic proximity Read